SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-006780
Filing Date
2020-03-25
Accepted
2020-03-25 09:15:54
Documents
15
Period of Report
2020-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K nc10009726x2_8k.htm   iXBRL 8-K 35706
2 FACT SHEET nc10009726x2_ex99-1.htm EX-99.1 27022
7 logo_bms.jpg GRAPHIC 3070
  Complete submission text file 0001140361-20-006780.txt   270994

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20200325.xsd EX-101.SCH 5262
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20200325_def.xml EX-101.DEF 19111
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20200325_lab.xml EX-101.LAB 29627
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20200325_pre.xml EX-101.PRE 21468
16 EXTRACTED XBRL INSTANCE DOCUMENT nc10009726x2_8k_htm.xml XML 9702
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 20740162
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences